Strategies to Reduce Health Disparities and Improve Outcomes in Breast and Prostate Cancer
The goal of this initiative is to increase awareness, knowledge, and competence in the need for culturally sensitive, evidence-based, guideline recommended approaches for the treatment of breast and prostate cancer in Black patients.
Provided by the National Comprehensive Cancer Network in partnership with The France Foundation
This program is designed to meet the educational needs of oncologists, nurse practitioners, physician assistants, and other health care professionals involved in the treatment and management of patients with breast and prostate cancers.
Following this activity, participants should be able to:
- Identify the variables contributing to health disparities in the management of breast and prostate cancer in Black patients
- Select appropriate therapy based on evidence-based guidance and individual patient characteristics and needs
- Describe comorbidities that are particularly prevalent in Black patients, drug-drug interactions, dosing considerations, and treatment side effects
- Explain the need for culturally sensitive communication and shared decision-making strategies when discussing disease and treatment information
- Develop effective patient communication strategies to improve care of Black patients with cancer
NCCN Continuing Education Disclosure Policy
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates and discloses to learners all relevant financial relationships.
In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing.
Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.
All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.
Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.
Full disclosure of faculty relationships is made prior to each module in this series.
This program has been approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, physician assistants, and other health care professionals. Complete accreditation information is provided before each individual educational activity.
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability
- One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer is no longer supported
- Adobe Reader or other PDF reader software for certificate viewing/printing